Pharmaceuticals and Health Policy

International Perspectives on Provision and Control of Medicines
1. Auflage 2022
ISBN: 978-1-032-25212-4
Verlag: Taylor & Francis

Buch, Englisch, 276 Seiten, Format (B × H): 140 mm x 216 mm, Gewicht: 467 g

Reihe: Routledge Library Editions: Health, Disease and Society

Originally published in 1981, this comprehensive volume is intended for medical economists, clinical pharmacologists, physicians, pharmacists and consumers, as well as planner and administrators who must determine relevant policy and legislation in the area of the provision of medicines. The contributors believe that the system of drugs provision can benefit from being studied, by policy revisions and evaluation of the outcomes of policy operations.

Autoren/Hrsg.

Blum, Richard

Herxheimer, Andrew

Stenzl, Catherine

Woodcock, Jasper

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Medizin, Gesundheit: Sachbuch, Ratgeber
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Gesundheitssystem, Gesundheitswesen

Inhaltsverzeichnis

1. Medicines – The Interested Parties 2. The Use of Medicines for Illness 3. The Introduction of New Drugs 4. The Promotion of Prescription Drugs and Other Puzzles 5. Information and Education About Drugs 6. Factors Affecting Individual Use of Medicines 7. Economic Considerations in the Provision and Use of Medicines8. The Role of International Organisations in Medicines Policy 9. Coherent Policies on Drugs: Formulation and Implementation

Über Autor(innen)

Richard Blum was Chairman of the International Research Group for Drug Legislation and Programs. Andrew Herxheimer was a consultant at the Charing Cross Hospital in London and Professor of Pharmacology at the University of Groningen, The Netherlands. Catherine Stenzl was Coordinator of the International Research Group for Drug Legislation and Programs. Jasper Woodcock was Director of the Institute for the Study of Drug Dependence London.